Rett Syndrome Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Rett Syndrome Market is segmented By Therapies (Current Therapies, Emerging Therapies), By Type of Rett Syndrome (Classic, Atypical), By Geography (No....
Rett Syndrome Market Size
Market Size in USD
CAGR13%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 13% |
| Market Concentration | High |
| Major Players | Anavex Life Sciences, AMO Pharma, Neurogene Inc, Taysha Gene Therapies Inc, Neuren Pharmaceuticals Ltd |
please let us know !
Rett Syndrome Market Analysis
The Rett Syndrome Market is estimated to be valued at USD 378.2 million in 2024 and is expected to reach USD 510.1 million by 2031, growing at a compound annual growth rate (CAGR) of 13% from 2024 to 2031.
The market is expected to witness positive growth over the forecast period. The key factors driving the growth of Rett syndrome market are increasing research and development activities for novel treatment options and growing awareness initiatives by government and non-government organizations. Rett syndrome is a rare genetic brain disorder that occurs almost exclusively in girls and slowly destroys motor and cognitive skills achieved in the first years of life. Currently, there is no cure for Rett syndrome but only treatments available are aimed at improving symptoms. Several pharmaceutical companies are conducting late-stage clinical trial for new drug candidates to treat Rett syndrome symptoms which is further expected to strongly impact the market growth positively during the forecast period.